Nicole LaBrosse - SVP, CHIEF FINANCIAL OFFICER at HALOZYME THERAPEUTICS, INC.

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp, Chief Financial Officer
Issuer Symbol
HALO on Nasdaq
All Insider Reports
All Insider Reports

Nicole LaBrosse - trading volume in the past year for HALOZYME THERAPEUTICS, INC.

Holdings reported by Nicole LaBrosse for HALOZYME THERAPEUTICS, INC.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 38,494 $2,719,216 $70.64 23 Feb 2026 Direct
Restricted Stock Units 15,995 $1,158,638 $57.75 20 Feb 2026 Direct Common Stock
Option to Purchase Common Stock 812 $313,504 $13.87 10 Sep 2025 Direct Common Stock
Performance Stock Units 36,357 $0 $58.29 23 Feb 2026 Direct Common Stock

Transactions reported by Nicole LaBrosse for HALOZYME THERAPEUTICS, INC.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.